ReviewDrug safety2003
Benefit-risk assessment of treatments for heparin-induced thrombocytopenia.
Harry Messmore et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papertrialcites it
ReviewDrug safety2003
Harry Messmore et al.PubMed ↗Publisher ↗
No numbers read from the abstract.